CCOC(=O)c1cc(C2CCN(CC(C)CC)C2=S)c(C(=O)/C=C(/C)N)[nH]1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?